As shown in Figure 3A, none of the CAR T cells exhibited cytotoxicity against B7-H3-negative Nalm6 leukemia cells or B7-H3-knockout NBEB neuroblastoma cells (NBEB B7-H3KO), confirming target-specific activity. This evidence concerns the gene CD276 and leukemia.